Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability

Molecular Biology of the Cell

Volumn 9, Issue 2, 1998, Pages 469-481

  Claffey, Kevin P ^a   Shih, Shu Ching ^a   Mullen, Andrew ^a   Dziennis, Suzan ^a   Cusick, Jennifer L ^a   Abrams, Kristin R ^a   Lee, Sam W ^a   Detmar, Michael ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; LUCIFERASE; MESSENGER RNA; RNA BINDING PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CROSS LINKING; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; HYPOXIA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RNA TRANSCRIPTION; TUMOR GROWTH; ULTRAVIOLET RADIATION;

EID: 0031930069     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.9.2.469     Document Type: Article

References (71)

1. Adamis, A.P., Miller, J.W., Bernal, M.T., D'Amico, D.J., Folkman, J., Yeo, T.K., and Yeo, K.T. (1994). Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118, 445-450.
2. Aiello, L.P., et al (1994). Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders [see comments]. N. Engl. J. Med. 331, 1480-1487.
3. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., and Keshet, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1, 1024-1028.
4. Aziz, N., and Munro, H.N. (1987). Iron regulates ferritin mRNA translation through a segment of its 5′ untranslated region. Proc. Natl. Acad. Sci. USA 84, 8478-8482.
5. Bohjanen, P.R., Petryniak, B., June, C.H., Thompson, C.B., and Lindsten, T. (1991). An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3′ untranslated region of lymphokine mRNA. Mol. Cell. Biol. 11, 3288-3295.
6. Bohjanen, P.R., Petryniak, B., June, C.H., Thompson, C.B., and Lindsten, T. (1992). AU RNA-binding factors differ in their binding specificities and affinities. J. Biol. Chem. 267, 6302-6309.
7. Brewer, G. (1991). An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11, 2460-2466.
8. Brown, L., Berse, B., Jackman, R., Tognazzi, K., Guidi, A., Dvorak, H., Senger, D., Connolly, J., and Schnitt, S. (1995a). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol. 26, 86-91.
9. Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Dvorak, H.F., and Senger, D.R. (1993a). Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 143, 1255-1262.
10. Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Senger, D.R., and Dvorak, H.F. (1993b). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 53, 4727-4735.
11. Brown, L.F., Olbricht, S.M., Berse, B., Jackman, R.W., Matsueda, G., Tognazzi, K.A., Manseau, E.J., Dvorak, H.F., and Van De Water, L. (1995b). Overexpression of vascular permeability factor (VPF/ VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J. Immunol. 154, 2801-2807.
12. Chen, C.Y., and Shyu, A.B. (1995). AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20, 465-470.
13. Claffey, K.P., Brown, L.F., del Aguila, L.F., Tognazzi, K., Yeo, K.T., Manseau, E.J., and Dvorak, H.F. (1996). Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 56, 172-181.
14. Claffey, K.P., and Robinson, G.S. (1996). Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev. 15, 165-176.
15. Conn, G., Bayne, M.L., Soderman, D.D., Kwok, P.W., Sullivan, K.A., Palisi, T.M., Hope, D.A., and Thomas, K.A. (1990). Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 87, 2628 -2632.
16. Connolly, D.T., Heuvelman, D.M., Nelson, R., Olander, J.V., Eppley, B.L., Delfino, J.J., Siegel, N.R., Leimgruber, R.M., and Feder, J. (1989). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84, 1470-1478.
17. Czyzyk-Krzeska, M.F., and Beresh, J.E. (1996). Characterization of the hypoxia-inducible protein binding site within the pyrimidinerich tract in the 3′-untranslated region of the tyrosine hydroxylase mRNA. J. Biol. Chem. 271, 3293-3299.
18. Czyzyk-Krzeska, M.F., Dominski, Z., Kole, R., and Millhorn, D.E. (1994a). Hypoxia stimulates binding of a cytoplasmic protein to a pyrimidine-rich sequence in the 3′-untranslated region of rat tyrosine hydroxylase mRNA. J. Biol. Chem. 269, 9940-9945.
19. Czyzyk-Krzeska, M.F., Furnari, B.A., Lawson, E.E., and Millhorn, D.E. (1994b). Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells. J. Biol. Chem. 269, 760-764.
20. Dvorak, H.F., Nagy, J.A., Berse, B., Brown, L.F., Yeo, K.-T., Yeo, T.-K., Dvorak, A.M., Van De Water, L., Sioussat, T.M., and Senger, D.R. (1992). Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann. N.Y. Acad. Sci. 667, 101-111.
21. Ebert, B.L., Firth, J.D., and Ratcliffe, P.J. (1995). Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences. J. Biol. Chem, 270, 29083-29089.
22. Fava, R., Olsen, N., Spencer-Green, G., Yeo, K.-T., Yeo, T.-K., Berse, B., Jackman, R., Senger, D., Dvorak, H., and Brown, L. (1994). Vascular permeability factor/endothelial growth factor (VPF/ VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180, 341-346.
23. Ferrara, N., and Henzel, W.J. (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 267, 851-858.
24. Ferrara, N., Houck, K.A., Jakeman, L.B., Winer, J., and Leung, D.W. (1991a). The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47, 211-218.
25. Ferrara, N., Leung, D.W., Cachianes, G., Winer, J., and Henzel, W.J. (1991b). Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. Methods Enzymol. 198, 391-405.
26. Gillis, P., and Malter, J.S. (1991). The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs. J. Biol. Chem. 266, 3172-3177.
27. Gorospe, M., and Baglioni, C. (1994). Degradation of unstable interleukin-1 alpha mRNA in a rabbit reticulocyte cell-free system. Localization of an instability determinant to a cluster of AUUUA motifs. J. Biol. Chem. 269, 11845-11851.
28. Gospodarowicz, D., Abraham, J.A., and Schilling, J. (1989), Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. USA 86, 7311-7315.
29. Graven, K.K., Troxler, R.F., Kornfeld, H-, Panchenko, M.V., and Farber, H.W. (1994). Regulation of endothelial cell glyceraldehyde-3-phosphare dehydrogenase expression by hypoxia. J. Biol. Chem. 269, 24446-24453.
30. Hashimoto, E., Ogita, T., Nakaoka, T., Matsuoka, R., Takao, A., and Kira, Y. (1994). Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am. J. Physiol. 267, 1948-1954.
31. Ikeda, E., Achen, M.G., Breier, G., and Risau, W. (1995). Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270, 19761-19766.
32. Jaeger, J.A., Turner, D.H., and Zuker, M. (1989a). Improved predictions of secondary structures for RNA. Proc. Natl. Acad. Sci, USA 86, 7706-7710.
33. Jaeger, J.A., Turner, D.H., and Zuker, M. (1989b). Predicting optimal and suboptimal secondary structure for RNA. Methods Enzymol. 183, 281-306.
34. Katz, D.A., Theodorakis, N.G., Cleveland, D.W., Lindsten, T., and Thompson, C.B. (1994). AU-A, an RNA-binding activity distinct from hnRNP A1, is selective for AUUUA repeats and shuttles between the nucleus and the cytoplasm. Nucleic Acids Res. 22, 238-246.
35. Keck, P.J., Hauser, S.D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D.T. (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312.
36. Ladoux, A., and Frelin, C. (1993). Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem. Biophys. Res. Commun. 195, 1005-1010.
37. Lagnado, C.A., Brown, C.Y., and Goodall, G.J. (1994). AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell. Biol. 14, 7984-7995.
38. Lee, S.W., Tomasetto, C., and Sager, R. (1991). Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc. Natl. Acad. Sci. USA 88, 2825-2829.
39. Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V., and Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
40. Levy, A.P., Levy, N.S., and Goldberg, M.A. (1996a). Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J. Biol. Chem. 271, 25492-25497.
41. Levy, A.P., Levy, N.S., and Goldberg, M.A. (1996b). Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271, 2746-2753.
42. Levy, A.P., Levy, N.S., Wegner, S., and Goldberg, M.A. (1995). Transecriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270, 13333-13340.
43. Levy, A.P., Tamargo, R., Brem, H., and Nathans, D. (1989). An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 2, 9-19.
44. Liu, Y., Cox, S.R., Morita, T., and Kourembanas, S. (1995). Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77, 638-643.
45. Malter, J.S. (1989). Identification of an AUUUA-specific messenger RNA binding protein. Science 246, 664-666.
46. Malter, J.S., and Hong, Y. (1991). A redox switch and phosphorylation are involved in the post-translational up-regulation of the adenosine-uridine binding factor by phorbol ester and ionophore. J. Biol. Chem. 266, 3167-3171.
47. Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A., and Chambon, P. (1983). Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10, 7895-7903.
48. Minchenko, A., Salceda, S., Bauer, T., and Caro, J. (1994). Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell. Mol. Biol. 40, 35-39.
49. Mukhopadhyay, D., Tsiokas, L., Zhou, X.M., Foster, D., Brugge, J.S., and Sukhatme, V.P. (1995). Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375, 577-581.
50. Nagy, E., and Rigby, W.F. (1995). Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J. Biol. Chem. 270, 2755-2763.
51. Nakagawa, J., Waldner, H., Meyer-Monard, S., Hofsteenge, J., Jeno, P., and Moroni, C. (1995). AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc. Natl. Acad. Sci. USA 92, 2051-2055.
52. Pierce, E.A., Avery, R.L., Foley, E.D., Aiello, L.P., and Smith, L.E. (1995). Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92, 905-909.
53. Plate, K.H., Breier, G., Weich, H.A., and Risau, W. (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845-848.
54. Sabri, M.N., DiSciascio, G., Cowley, M.J., Alpert, D., and Vetrovec, G.W. (1991). Coronary collateral recruitment: functional significance and relation to rate of vessel closure. Am. Heart J. 121, 876-880._
55. Schuler, G.D., and Cole, M.D. (1988). GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor. Cell 55, 1115-1122.
56. Senger, D.R., Connolly, D.T., Van De Water, L., Feder, J., and Dvorak, H.F. (1990). Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res. 50, 1774-1778.
57. Shaw, G., and Kamen, R. (1986). A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
58. Shima, D.T., Deutsch, U., and D'Amore, P.A. (1995). Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett. 370, 203-208.
59. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
60. Stein, I., Neeman, M., Shweiki, D., Itin, A., and Keshet, E. (1995). Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15, 5363-5368.
61. Stephens, C.M., and Bauerle, R. (1992). Essential cysteines in 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Escherichia coli. Analysis by chemical modification and site-directed mutagenesis of the phenylalanine-sensitive isozyme. J. Biol. Chem. 267, 5762-5767.
62. Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T., and Keshet, E. (1995). Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738-4747.
63. Tischer, E., Mitchell, R., Hartman, T., Suva, M., Gospodarowicz, D., Fiddes, J.C., and Abraham, J.A. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954.
64. Vakalopoulou, E., Schaack, J., and Shenk, T. (1991). A 32-kilodalton protein binds to AU-rich domains in the 3′ untranslated regions of rapidly degraded mRNAs. Mol. Cell. Biol. 11, 3355-3364.
65. Wang, G.L., and Semenza, G.L. (1993). Characterization of hypoxiainducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268, 21513-21518.
66. Wang, X., Kiledjian, M., Weiss, I.M., and Liebhaber, S.A. (1995). Detection and characterization of a 3′ untranslated region ribonucleoprotein complex associated with human alpha-globin mRNA stability (published erratum appears in Mol. Cell. Biol. 15:2331/ 1995). Mol. Cell. Biol. 15, 1769-1777.
67. Weindel, K., Moringlane, J.R., Marme, D., and Weich, H.A. (1994). Detection and quantification of vascular endothelial growth factor/ vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery 35, 439-448; discussion 448-439.
68. You, Y., Chen, C.Y., and Shyu, A.B. (1992). U-rich sequence-binding proteins (URBPs) interacting with a 20-nucleotide U-rich sequence in the 3′ untranslated region of c-fos mRNA may be involved in the first step of C-fos mRNA degradation. Mol. Cell. Biol. 12, 2931-2940.
69. Zhang, W., Wagner, B.J., Ehrenman, K., Schaefer, A.W., DeMaria, C.T., Crater, D., DeHaven, K., Long, L., and Brewer, G. (1993). purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13, 7652-7665.
70. Zubiaga, A.M., Belasco, J.G., and Greenberg, M.E. (1995). The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell. Biol. 15, 2219-2230.
71. Zuker, M. (1989). On finding all suboptimal foldings of an RNA molecule. Science 244, 48-52.